HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

AbstractPURPOSE:
The tumor mRNA expression levels of mammaglobin, a novel breast-specific and breast cancer-associated marker, were correlated with disease outcome in 280 patients with primary breast cancer.
PATIENTS AND METHODS:
Mammaglobin expression levels were assessed by quantitative reverse transcriptase polymerase chain reaction in frozen tumor tissue from breast cancer patients with a median age of 60 years (range, 30 to 88 years) and a median follow-up of 85 months (range, 2 to 169 months).
RESULTS:
High expression levels were associated with low-grade tumors (P =.018), with positive estrogen and progesterone receptor status (P <.001), and postmenopausal status (P =.010). In the analysis of all patients, low tumor mammaglobin expression levels predicted an early relapse both in Cox univariate (hazard ratio [HR], 0.52; 95% CI, 0.34 to 0.79; P =.002) and multivariate regression analyses corrected for the traditional prognostic factors (HR, 0.55; 95% CI, 0.35 to 0.88; P =.012). The association of mammaglobin expression with the rate of relapse was particularly favorable in patients who received adjuvant tamoxifen treatment (HR, 0.35; 95% CI, 0.17 to 0.71; P =.004).
CONCLUSION:
These results demonstrate that the assessment of the tumor mRNA expression level of the breast-specific protein mammaglobin could be useful to stratify patients for individual adjuvant treatment strategies.
AuthorsPaul N Span, Esmé Waanders, Peggy Manders, Joop J T M Heuvel, John A Foekens, Mark A Watson, Louk V A M Beex, Fred C G J Sweep
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 22 Issue 4 Pg. 691-8 (Feb 15 2004) ISSN: 0732-183X [Print] United States
PMID14966093 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Mammaglobin A
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • SCGB2A2 protein, human
  • Uteroglobin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (genetics, metabolism)
  • Breast Neoplasms (metabolism, mortality, pathology)
  • Disease-Free Survival
  • Female
  • Humans
  • Mammaglobin A
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Proteins (genetics, metabolism)
  • Netherlands (epidemiology)
  • Postmenopause
  • RNA, Messenger (metabolism)
  • RNA, Neoplasm (metabolism)
  • Regression Analysis
  • Uteroglobin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: